(*) EU Approval Date: 2021. 12.10.
(*) JP Approval Date: 2021. 09.30.
(*) UK Approval Date: 2021. 09.09.
(*) USA Approval Date: 2022. 01.14
Company
Generic Name: Abrocitinib
JAK: JAnus Kinase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 09.07
TM
TM Web-Site